Literature DB >> 12905916

Beyond "bad news": the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the age of biomedicine (1945-1995).

Peter Keating1, Alberto Cambrosio.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12905916      PMCID： PMC1044630     

Source DB:  PubMed          Journal:  Med Hist        ISSN： 0025-7273            Impact factor:   1.419


× No keyword cloud information.
  52 in total

1.  Diagnostic evaluation and clinical staging in Hodgkin's disease: usefulness and problems of the Ann Arbor staging classification in primary staging and staging in relapse.

Authors:  J E Ultmann; E M Moran
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

2.  End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and-or radiotherapy (47 cases) or with concurrent infection (5 cases).

Authors:  T R Miller; J T Nicholson
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

3.  Reticulum cell sarcoma treated by radiotherapy. Significance of clinical features upon the prognosis.

Authors:  H S Hansen
Journal:  Acta Radiol Ther Phys Biol       Date:  1969-12

4.  Reticulum-cell sarcoma. 3. Prognosis.

Authors:  J Newall; M Friedman
Journal:  Radiology       Date:  1970-10       Impact factor: 11.105

5.  Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy.

Authors:  C C Wang; D J Fleischli
Journal:  Cancer       Date:  1968-11       Impact factor: 6.860

6.  Primary management of advanced lymphosarcoma with radiotherapy.

Authors:  R E Johnson; G T O'Conor; D Levin
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

7.  Clinical and radiotherapeutic aspects of reticulum cell sarcoma.

Authors:  U Tikka; K Malmio
Journal:  Acta Radiol Ther Phys Biol       Date:  1969-12

8.  Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials.

Authors:  H S Kaplan; S A Rosenberg
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

9.  Prophylactic treatment of adjacent areas in Hodgkin's disease.

Authors:  M V Peters
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  Prognosis of stage I lymphosarcoma and reticulum-cell sarcoma.

Authors:  A Lipton; B J Lee
Journal:  N Engl J Med       Date:  1971-02-04       Impact factor: 91.245
View more
  2 in total

1.  Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphoma.

Authors:  Mohamed Osman Azzazi; Hany Mohamed Hegab; Amro Mohamed Sedky El-Ghammaz; Heba Mohamed Saber; Youssef Adel Afifi
Journal:  Clin Exp Med       Date:  2021-07-03       Impact factor: 3.984

2.  Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy.

Authors:  Giorgio Broccia; Jonathan Carter; Cansu Ozsin-Ozler; Federico Meloni; Sara De Matteis; Pierluigi Cocco
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.